Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Deepa Naishadham

Showing results (11-20 of 26) with videos related to

Pageof 3
Sort By:
Gastroenterology|February 22, 2011
Iron levels in hepatocytes and portal tract cells predict progression and outcomes of patients with advanced chronic hepatitis CRichard W Lambrecht, Richard K Sterling, Deepa Naishadham, et al.
American Journal of Industrial Medicine|November 6, 2007
Social disparities in the burden of occupational exposures: results of a cross-sectional studyMargaret M Quinn, Grace Sembajwe, Anne M Stoddard, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 11, 2008
Serum fibrosis marker levels decrease after successful antiviral treatment in chronic hepatitis C patients with advanced fibrosisRobert J Fontana, Herbert L Bonkovsky, Deepa Naishadham, et al.
Hepatology (Baltimore, Md.)|January 5, 2008
Relationship of serum fibrosis markers with liver fibrosis stage and collagen content in patients with advanced chronic hepatitis CRobert J Fontana, Zachary D Goodman, Jules L Dienstag, et al.
Gut|August 3, 2010
Serum fibrosis markers are associated with liver disease progression in non-responder patients with chronic hepatitis CRobert J Fontana, Jules L Dienstag, Herbert L Bonkovsky, et al.
Cancer|January 10, 2012
Predicting US- and state-level cancer counts for the current calendar year: Part I: evaluation of temporal projection methods for mortalityHuann-Sheng Chen, Kenneth Portier, Kaushik Ghosh, et al.
The American Journal of Gastroenterology|December 9, 2010
Development and progression of portal hypertensive gastropathy in patients with chronic hepatitis CRobert J Fontana, Arun J Sanyal, Marc G Ghany, et al.
Journal of Urban Health : Bulletin of the New York Academy of Medicine|July 18, 2006
Issues in design and implementation in an urban birth cohort study: the Syracuse AUDIT projectJudith A Crawford, Teresa M Hargrave, Andrew Hunt, et al.
Journal of Hepatology|July 16, 2008
DNA polymorphisms and response to treatment in patients with chronic hepatitis C: results from the HALT-C trialTimothy R Morgan, Richard W Lambrecht, Herbert L Bonkovsky, et al.
Cancer|January 10, 2012
Predicting US- and state-level cancer counts for the current calendar year: Part II: evaluation of spatiotemporal projection methods for incidenceLi Zhu, Linda W Pickle, Kaushik Ghosh, et al.
Pageof 3

Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Gastroenterology|February 22, 2011
Iron levels in hepatocytes and portal tract cells predict progression and outcomes of patients with advanced chronic hepatitis CRichard W Lambrecht, Richard K Sterling, Deepa Naishadham, et al.
American Journal of Industrial Medicine|November 6, 2007
Social disparities in the burden of occupational exposures: results of a cross-sectional studyMargaret M Quinn, Grace Sembajwe, Anne M Stoddard, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 11, 2008
Serum fibrosis marker levels decrease after successful antiviral treatment in chronic hepatitis C patients with advanced fibrosisRobert J Fontana, Herbert L Bonkovsky, Deepa Naishadham, et al.
Hepatology (Baltimore, Md.)|January 5, 2008
Relationship of serum fibrosis markers with liver fibrosis stage and collagen content in patients with advanced chronic hepatitis CRobert J Fontana, Zachary D Goodman, Jules L Dienstag, et al.
Gut|August 3, 2010
Serum fibrosis markers are associated with liver disease progression in non-responder patients with chronic hepatitis CRobert J Fontana, Jules L Dienstag, Herbert L Bonkovsky, et al.
Cancer|January 10, 2012
Predicting US- and state-level cancer counts for the current calendar year: Part I: evaluation of temporal projection methods for mortalityHuann-Sheng Chen, Kenneth Portier, Kaushik Ghosh, et al.
The American Journal of Gastroenterology|December 9, 2010
Development and progression of portal hypertensive gastropathy in patients with chronic hepatitis CRobert J Fontana, Arun J Sanyal, Marc G Ghany, et al.
Journal of Urban Health : Bulletin of the New York Academy of Medicine|July 18, 2006
Issues in design and implementation in an urban birth cohort study: the Syracuse AUDIT projectJudith A Crawford, Teresa M Hargrave, Andrew Hunt, et al.
Journal of Hepatology|July 16, 2008
DNA polymorphisms and response to treatment in patients with chronic hepatitis C: results from the HALT-C trialTimothy R Morgan, Richard W Lambrecht, Herbert L Bonkovsky, et al.
Cancer|January 10, 2012
Predicting US- and state-level cancer counts for the current calendar year: Part II: evaluation of spatiotemporal projection methods for incidenceLi Zhu, Linda W Pickle, Kaushik Ghosh, et al.
Pageof 3